跳至主要内容
临床试验/NCT03435185
NCT03435185已完成不适用

Greater Occipital and Supraorbital Nerve Blockade For The Preventive Treatment of Migraine

Dr. Lutfi Kirdar Kartal Training and Research Hospital0 个研究点目标入组 103 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
103
主要终点
Change of Frequency of Headache

研究概览

简要总结

The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.

详细描述

A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to GON and SON in the blockade patients. Placebo patients received 2 ml 0.9% saline in the same way. Patients were blinded to kind of injection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
  • 18 ≥ years old
  • Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.

排除标准

  • Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
  • Allergies to local anesthetics
  • Hemorrhagic diathesis
  • Alcohol or drug abuse

结局指标

主要结局

Change of Frequency of Headache

时间窗: Patients were followed up from baseline to 2 months after first injection.

Number of headache days in a month. Scores from both months were averaged. Minimum=0 Maximum=30. Lower scores mean a better outcome.

Change of Severity of Headache

时间窗: Patients were followed up for 2 months from baseline after first injection.

Mean visual analog scale (VAS) scores. Scores from both months were avareged. Minimum=0 Maximum=10. Lower scores mean a better outcome

次要结局

未报告次要终点

研究者

发起方
Dr. Lutfi Kirdar Kartal Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Cem Bölük

Medical Doctor

Dr. Lutfi Kirdar Kartal Training and Research Hospital

相似试验